We describe here a novel approach for detecting and quantitating human respiratory syncytial virus (RSV) based on expression of a reporter gene from an RSV minigenome. BHK cells were cytoplasmically transformed with a noncytopathic Sindbis virus replicon expressing T7 RNA polymerase. These cells were then cotransfected with T7 expression plasmids that contain the cDNA of an RSV minigenome and the genes for RSV nucleocapsid proteins N, P, and L. The minigenome contains a reporter gene such as lacZ or CAT flanked by cis-acting RSV transcription signals. Subsequent infection of these cells with RSV resulted in a high level of reporter gene expression which could be inhibited by ribavirin. Mock-infected cells exhibited background levels of expression. This assay can be used to quantitate RSV and titer neutralizing antibody and may be a valuable tool for screening compounds for anti-RSV activity. It serves as a prototype for other negative-strand RNA viruses.
INTRODUCTION
Human respiratory syncytial virus (RSV) is a member of the order Mononegavirales (nonsegmented, negativestranded RNA genome), family Paramyxoviridae, and genus Pneumovirus (Collins et al., 1996a) . RSV is the leading cause of pneumonia and bronchiolitis in infants. Premature infants, infants with lung problems, and patients who are immunocompromised are at risk for severe RSV disease. The only drug approved for treatment of RSV is the inosine monophosphate dehydrogenase inhibitor, ribavirin (Virazole, ICN Pharmaceuticals, Inc., Costa Mesa, CA) (Hall et al., 1983) . A preparation of human immune globulin (RespiGam, MedImmune, Frederick, MD) has been approved for prophylaxis of RSV disease for certain high-risk infants, but no vaccine has been licensed to prevent RSV infection (Groothius et al., 1993; Murphy and Collins, 1997) .
Techniques for manipulating RNA virus genomes have greatly facilitated genetic analyses of these viruses and have enabled virologists to employ RNA viruses in ways initially limited to DNA viruses. Construction of attenuated RNA virus vaccines, use of RNA viruses as vectors for foreign gene expression, and use of RNA viruses as gene therapy vectors are just some of the novel applications under development. Most of the early results in this area were accomplished with positive-strand RNA viruses (Bredenbeek and Rice, 1992; Schlesinger, 1995) .
Recently a number of laboratories have described advances in the genetic manipulation of various members of the Mononegavirales. Recovery of infectious rabies virus, Sendai virus, vesicular stomatitis virus, measles virus, and RSV, for example, has been accomplished by using T7 RNA polymerase to generate full-length antigenomic transcripts from cDNA together with the viral proteins necessary for assembly of a nucleocapsid and for RNA replication and transcription (Schnell et al., 1994; Collins et al., 1995; Garcin et al., 1995; Lawson et al., 1995; Radecke et al., 1995; Whelan et al., 1995) .
We thought that a variation of this strategy could be used to develop an assay for the detection of negativestrand RNA viruses. Our idea was to derive cell lines that contain a reporter gene that would be expressed only after infection with a particular RNA virus. A prototype cell line, BHKSINLuc2, has been described for detection of Sindbis virus, a positive-strand virus (Olivo et al., 1994) . BHKSINLuc2 cells constitutively express an RNA molecule that is transcribed in the nucleus from an RNA polymerase II promoter. This transcript is a defective Sindbis RNA, which contains the gene for firefly luciferase under the control of the Sindbis virus subgenomic RNA promoter. Infection of BHKSINLuc2 cells with Sindbis virus leads to replication of this defective RNA, transcription of luciferase mRNA, and high levels of luciferase activity.
Recent work in a number of laboratories has defined the cis-acting elements required for the replication and transcription of several negative-strand virus genomes, including RSV. This information has been used to con-struct synthetic analogues of genomic RNA, referred to as minigenome RNA (Collins et al., 1991) . RNA transcribed from minigenome cDNA contains the cis-acting elements necessary for replication and transcription in RSV-infected cells and contains a reporter gene(s) in place of viral genes. Our goal was to express such an RSV minigenome constitutively in the cytoplasm of cells so that infection with RSV would lead to reporter gene expression analogous to our results with BHKSINLuc2 cells and Sindbis virus.
The most widely used cytoplasmic RNA expression system is the vaccinia virus/T7 RNA polymerase system. There, infection with a recombinant vaccinia virus supplies intracellular T7 RNA polymerase, and the gene to be expressed is supplied as a transfected plasmid under the control of the T7 promoter (Fuerst et al., 1987; ElroyStein and Moss, 1990 ). For our purposes vaccinia infection was problematic; a system that uses stably transformed cells would be easier to handle and allow more widespread use. Recently noncytopathic Sindbis virus replicons have been developed (Frolov et al., 1996) . These replicons (SR19/pac) contain the gene for puromycin resistance (pac) under control of the Sindbis subgenomic RNA promoter. Transfection of SR19/pac RNA into BHK cells produces a population of puromycin-resistant cells due to constitutive replication and transcription of the noncytopathic replicon. Long-term expression of an additional foreign gene has been achieved in cells transformed with replicons that contain a second subgenomic RNA promoter (Lindenbach and Rice, 1997) . Cells that carry a replicon that expresses T7 RNA polymerase (SR19/T7pol/pac) can transcribe genes under the control of the T7 promoter following transfection of that DNA (Fig. 1A and E. Agapov et al., unpublished data) .
We have investigated ways to express an RSV minigenome using noncytopathic Sindbis virus replicons. In one strategy SR19/T7pol/pac-transformed cells were cotransfected with a plasmid containing the cDNA of an RSV minigenome downstream of a T7 promoter and plasmids containing the genes for RSV N, P, and L proteins under transcriptional control of a T7 promoter. When the minigenome contained the lacZ gene, these transfected cells exhibited RSV-dependent ␤-galactosidase activity (Fig. 1) . In this report we describe how such a system can be used to quantitate RSV and how it may be useful for titering neutralizing antibody and for screening anti-RSV drugs.
RESULTS AND DISCUSSION
T7 RNA polymerase is functional in BHK cells that have been transfected with SR19/T7pol/pac RNA BHK cells electroporated with SR19/T7pol/pac RNA were selected for puromycin resistance (Lindenbach and Rice, 1997) . To demonstrate that these cells expressed a functional T7 RNA polymerase, we transfected them with a plasmid (pTM1-LacZ) in which the Escherichia coli lacZ gene is under control of a T7 promoter. Following transfection of pTM1-LacZ, high levels of ␤-galactosidase activity were detected in these cells, but not in control cells that lacked the T7 RNA polymerase (Fig. 2) .
BHK cells are susceptible to RSV infection and support minigenome replication and transcription
To determine whether SR19/T7pol/pac-transfected cells were permissive for RSV infection and minigenome replication and expression, we transfected in vitro-synthesized minigenome RNA into BHK cells that had been infected with RSV or had been mock-infected using the protocol described by Collins et al. for human 293 cells (Collins et al., 1991) . Only RSV-infected cells exhibited reporter gene expression (data not shown). To determine whether minigenome RNA transcribed in vivo in SR19/ T7pol/pac cells was functional, we adopted a protocol analogous to that in which T7 RNA polymerase is delivered by a recombinant vaccinia virus, vTF7±3 . SR19/T7pol/pac cells were RSV-or mockinfected, and immediately following infection, the cells were transfected with a plasmid (pC2CAT) that contains minigenome cDNA under control of a T7 promoter and the chloramphenicol acetyltransferase (CAT) gene flanked by RSV transcription signals . Under these conditions we observed a marked increase in CAT activity in infected cells compared with mock-infected cells (data not shown). These results indicate that SR19/T7pol/pac-transformed BHK cells can substitute for vTF7±3-infected 293 cells in experiments that require the in vivo expression of a functional RSV minigenome.
Preformed minigenome RNA requires RSV nucleocapsid proteins for activity after RSV infection
Replication and transcription of RSV minigenomes are strictly dependent on trans-acting viral proteins, whether supplied by coinfection with standard RSV or from transfected plasmids expressing RSV proteins. This suggested a novel strategy whereby a minigenome could be used to detect RSV in cell culture. Specifically, a cell line would be prepared to constitutively express an RSV minigenome RNA, which contains the gene for a marker protein that can be detected sensitively. The negativesense nature of the minigenome would preclude its direct translation, but exposure of the cells to RSV infection would result in the synthesis of viral proteins, thereby complementing the replication of the RSV minigenome and the expression of its marker gene.
To test the feasibility of this strategy, we transfected SR19/T7pol/pac cells with the cDNA of a GFP-containing minigenome (MP210) and 6±24 h later infected the cells with RSV. Under these conditions, no RSV-dependent GFP expression was observed. Under analogous condi- (Lindenbach and Rice, 1997) . Puromycin-resistant cells are then transfected with a plasmid containing the cDNA of an RSV minigenome under the control of a T7 promoter and T7 expression plasmids containing the genes for the RSV nucleocapsid proteins L, N, and P. T7 RNA polymerase-mediated transcription of the RSV minigenome in the cytoplasm is followed by cleavage of the 3Ј and, for certain constructs, 5Ј ends, by ribozymes (E and F) that generate termini that are replication competent. Infection with RSV introduces all the RSV gene products necessary to replicate and transcribe the minigenome. Reporter gene mRNA is translated into an easily measured enzyme (e.g., ␤-galactosidase), which provides a surrogate marker of infection. (B) Major steps of the protocol. Following step 1D (puromycin selection) the cells can be frozen and used for multiple separate transfections.
tions in which the RSV minigenome was expressed in vTF7±3-infected cells and subsequently infected with RSV infection, reporter gene expression also was not detected (P.L.C., unpublished results). This suggests that infection with RSV is inefficient in complementing naked minigenome RNA premade in cells. We suspect that one factor is the very short half-life of naked intracellular minigenome RNA, and a second factor might involve the nonrobust nature of RSV infection in vitro.
It also has been shown that the N, P, and L proteins are necessary and sufficient for minigenome RNA replication but that transcription of genes greater than ϳ1000 nt is highly inefficient unless the M2±1 protein also is supplied Yu et al., 1995) . More specifically, expression of only the N and P proteins leads to encapsidation of minigenome RNA; addition of the L protein amplifies the amount of encapsidated minigenome RNA by 10-to 50-fold due to RSV-specific replication (Atreya et al., 1998) but yields little or no expression of relatively long genes such as ␤-galactosidase or luciferase; and the further addition of the M2±1 protein results in efficient marker gene expression. This suggested an alternative strategy whereby a minigenome expressed in the presence of the N, P, and L proteins would be stabilized and amplified without significant marker gene expression, and the subsequent introduction of viral proteins, in particular the M2±1 protein, by RSV infection would result in efficient marker gene expression.
To test this strategy, SR19/T7pol/pac cells or SR19/pac cells were transfected with a lacZ-containing minigenome cDNA (pMP210LacZ) with or without pTM1-N, pTM1-P, and pTM1-L. Six hours after transfection the cells were trypsinized and plated in 24-well dishes and 18 h later infected with RSV or mock-infected (Fig. 1) . We observed significant induction of ␤-galactosidase activity by RSV, and the induction was dependent on expression of both T7 RNA polymerase and the RSV nucleocapsid proteins N, P, and L (Fig. 3A) . To assess the relative requirement for each of the nucleocapsid proteins, we transfected various combinations of the N, P, and L expression plasmids. RSV-induced ␤-galactosidase activity was significant only in the presence of all three nucleocapsid proteins (Fig. 3B) . The activity of the SR19/T7pol cells in this assay was stable for Ն10 passages (data not shown).
When evaluated by histochemical staining, ␤-galactosidase-positive infected cells were detected only in the presence of the nucleocapsid proteins: a few stained infected cells per well were observed with N alone or with N plus P, but many stained infected cells were consistently seen when N, P, and L were all expressed (data not shown). No stained cells were observed in the absence of RSV with or without the nucleocapsid proteins. The requirement for all three nucleocapsid proteins in our assay suggests that encapsidation and replication of the minigenome RNA are necessary for efficient reporter gene expression by the incoming RSV. In addition, the lack of ␤-galactosidase activity with the
FIG. 3. RSV-dependent ␤-galactosidase activity. (A) Requirement for the nucleocapsid proteins. BHK cells transformed with a noncytopathic
Sindbis replicon that expresses T7 RNA polymerase (SR19/T7/pac) or the parent replicon (SR19/pac) that does not express T7 RNA polymerase were transfected with minigenome cDNA (1 g of pMP210LacZ) with or without pTM1-N, pTM1-L, and pTM1-P (0.2 g of each). Twenty hours after transfection the cells were trypsinized and plated into a multiwell plate. After 6 h the cells were infected with RSV or mockinfected, and 36 h later the cells were lysed and assayed for ␤-galactosidase. Results shown are the means of duplicate samples. (B) The three nucleocapsid proteins were all required for the induction of ␤-galactosidase by RSV. pMP210LacZ was either transfected alone or with various combinations of the nucleocapsid expression plasmids (pTM1-N, pTM1-L, and pTM1-P) as indicated. Results shown are the means of triplicate samples Ϯ the standard deviation.
FIG. 2.
Expression of ␤-galactosidase in Sindbis virus replicontransformed cells transfected with pTM1-LacZ. BHK cells were electroporated with either SR19/pac RNA or SR19/T7pol/pac RNA. Following selection with puromycin, the cells were transfected with pTM1 or pTM1-LacZ. Twenty-four hours later ␤-galactosidase activity was assayed using the CPRG substrate as described under Materials and Methods. Results shown are the means of duplicate samples.
nucleocapsid proteins in the absence of RSV suggests that RSV infection provides some factor(s) (e.g., M2±1 protein) necessary for transcription of lacZ mRNA Collins et al., 1996b) .
The level of expression of the minigenome reporter gene is dependent on the input concentration of RSV
The assay showed a relatively linear dose-response for RSV over a range of Ͼ1 log 10 (Fig. 4A) . The induced expression exhibited a plateau effect above an inoculum equivalent to a multiplicity of infection of ϳ0.6 PFU/cell (based on HEp2 cells). These results suggest that this assay could be used in place of a plaque assay to quantitate RSV stocks. We also measured ␤-galactosidase in SR19/T7pol/pac cells transfected with pMP210LacZ as a function of time after infection following a high m.o.i. (10 PFU/cell) or a low m.o.i. (0.2 PFU/cell). As shown in Fig. 4B , ␤-galactosidase activity following a low m.o.i. infection reached the same level as that following a high m.o.i. infection, but with a delay of ϳ48 h. This suggests that RSV replicates and spreads within the SR19/T7pol/ pac cell cultures and that the duration of an infectious cycle is ϳ48 h.
RSV-induced ␤-galactosidase activity in SR19/T7pol/ pac cells is sensitive to ribavirin Ribavirin inhibits in vitro replication of many RNA viruses including RSV (Sidwell et al., 1979) . Depending on the assay used, the 50% effective dose (ED 50 ) of ribavirin for RSV has been reported to be ϳ5 g/ml (Chiba et al., 1995) . Following transfection of pMP210LacZ, pTM1-N, pTM1-P, and pTM1-L, SR19/T7pol/pac cells were infected with RSV in the presence of several concentrations of ribavirin. ␤-Galactosidase activity was reduced to near background levels by as little as 1 g/ml ribavirin (Fig. 5A) . The ED 50 of ribavirin was determined to be Ͻ100 ng/ml (Fig. 5B) . Treatment of the cells with ribavirin (1 g/ml) from the time of transfection of the RSV cDNA plasmids until the time of RSV infection had no effect on RSV-dependent ␤-galactosidase expression (data not shown). This suggests that under the conditions this assay was performed, ribavirin primarily affects RSV replication and transcription rather than the Sindbis replicon or T7 polymerase transcription and that any L-proteinmediated minigenome replication that occurs prior to RSV replication must be relatively insensitive to ribavirin.
RSV-induced ␤-galactosidase activity in SR19/T7pol/ pac cells is sensitive to neutralizing antibody to RSV RSV is a highly prevalent human pathogen, and most adults have been infected at least once (Collins et al., 1996a) . Pooled human gamma globulin has, therefore, significant neutralizing activity against RSV. To demonstrate that the RSV-induced ␤-galactosidase activity in this system requires infectious virus and can, therefore, be blocked by neutralizing antibody, we incubated RSV with a sample of pooled human gamma globulin and then used the treated virus to infect SR19/T7pol/pac cells that had previously been transfected with pMP210LacZ and pTM1-N, P, and L. As shown in Fig. 6 , ␤-galactosidase activity was inversely proportional to the dilution of the gamma globulin.
Conclusions
We have designed an assay for RSV using a noncytopathic Sindbis replicon expressing the T7 RNA polymerase and cDNAs for T7-mediated expression of an RSV minigenome and the RSV nucleocapsid proteins. Our studies suggest that this approach could be of value in quantitating RSV, in screening antiviral drugs, and in evaluating the efficacy of vaccines. As illustrated in Fig.  1A , the molecular pathways involved in this method are complex, but, as with computer software, these complexities are invisible to the user. In addition, as outlined in Fig. 1B , the preparation of the cells requires two separate steps (electroporation of the replicon followed by puromycin selection and plasmid transfection), but once the cells are prepared, the protocols for virus inoculation, sample processing, and data readout are quite simple.
Virus activation of a reporter enzyme in genetically modified cells has been successfully applied to a DNA virus, a retrovirus, a positive-strand RNA virus, and, as shown here, a negative-strand RNA virus (Felber and Pavlakis, 1988; Rocancourt et al., 1990; Stabell and Olivo, 1992; Olivo et al., 1994; Olivo, 1996) . The molecular pathways involved in the replication of each of these viruses are quite different. These differences have necessitated that the strategies used to accomplish this general approach to virus detection be tailored to each virus group.
The strategy used for each group, however, can be viewed as a prototype for all members of that group because it should be possible to successfully apply it to any particular virus by incorporating virus-specific cisacting elements and trans-acting factors into the assay (Olivo, 1996) . Paramyxoviridae, for example, have very similar molecular pathways of replication and transcription; adapting our RSV method to human parainfluenzavirus type 3 (HPIV3) could be accomplished by using T7 expression plasmids that contain HPIV3 minigenome cDNA and the HPIV3 nucleocapsid genes (De and Banerjee, 1993) . As the molecular details of replication of all pathogenic human viruses are identified, it is likely that this approach to virus detection will be applied to many of these viruses.
MATERIALS AND METHODS

Cells and virus
BHK-21 cells were obtained from ATCC. The method to generate SR19/pac and SR19/T7pol/pac transformed BHK cells was described previously (Lindenbach and Rice, 1997) . Human RSV (strain A2) was propagated and titered on HEp-2 cells as described previously . cDNAs pTM1-N, pTM1-P, and pTM1-L were described in Grosfeld et al. (1995) . pTM1-LacZ was generated by cloning the ORF of lacZ into the NcoI-BamHI window of pTM1 (a generous gift of Bernard Moss). SR19/pac and SR19/T7pol/pac cDNA plasmids were a generous gift of Eugene Agapov and Charles Rice. pMP210 was made from the C2-LUC RSV minigenome construct (Collins et 
FIG. 6.
Effect of anti-RSV neutralizing antibody on the induction of ␤-galactosidase by RSV. The experimental protocol was the same as described in Fig. 3 except that prior to infection 25 l of RSV (titer 2 ϫ 10 7 PFU/ml assayed on Hep2 cells) was incubated with the indicated dilutions of human immune globulin at room temperature for 15 min. Control equals incubation in the absence of antibody. Results shown are the mean of duplicate samples.
al., 1996a) by inserting a PCR product containing the Green Lantern Protein gene (LifeTechnologies, Gaithesburg, MD) flanked by GS and GE signals into the BstXI site in the leader and by deleting the luciferase gene and inserting a 5Ј hammerhead ribozyme preceded by a unique AvrII site (Altschuler et al., 1992) . The 3Ј hammerhead ribozyme was replaced with a PCR product containing the antigenomic hepatitis ␦ virus ribozyme (Perrotta and Been, 1991) followed by a unique XhoI site. pMP210LacZ was made by replacing the ORF of GFP in pMP210 with the ORF of lacZ using the unique XbaI and XmaI sites.
Transfection protocol
All DNA transfections were performed using Lipofectamine (Life Technologies, Gaithesburg, MD) according to the manufacturer's directions.
␤-Galactosidase assay
␤-Galactosidase activity of cell lysates was measured using the substrate chlorophenol red-␤-Dgalactopyranoside (CPRG, Boehringer Mannheim, Indianapolis, IN) (final concentration 5 mM) in a 0.2 M potassium phosphate buffer, pH 7.8, with 1 mM MgCl 2 . Lysates were made in this buffer containing 1% Triton X-100 and 1 mM dithiothreitol. Fifty microliters of lysate were mixed with 50 l of substrate in a microtiter plate well. After incubation for 30 to 120 min at room temperature, the optical density at a wavelength of 562 nM (OD 562 ) was measured with a THERMOmax microplate reader using SOFTmax software (Molecular Devices, Sunnyvale, CA) . The assay was shown to be linear up to an OD 562 of 3.0.
